Lilly CEO wields manufacturing plans to push pharma-friendly policies
While announcing billions of dollars in new U.S. investments, company chief David Ricks called for an extension of 2017 tax cuts and changes to Medicare's drug negotiation program.


While announcing billions of dollars in new U.S. investments, company chief David Ricks called for an extension of 2017 tax cuts and changes to Medicare's drug negotiation program.